Biosafety Level-4 Laboratories in Europe: Opportunities for Public Health, Diagnostics, and Research

PLoS Pathogens

Volumn 9, Issue 1, 2013, Pages

  Nisii, Carla ^a   Castilletti, Concetta ^a   Raoul, Hervé ^b   Hewson, Roger ^c   Brown, David ^c   Gopal, Robin ^c   Eickmann, Markus ^d   Gunther, Stephan ^e   Mirazimi, Ali ^f   Koivula, Tuija ^f   Feldmann, Heinz ^g   Di Caro, Antonino ^a   Capobianchi, Maria R ^a   Ippolito, Giuseppe ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b INSERM   (France)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

^e BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^f SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^g NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL;

ARTICLE; BIOSAFETY; BLOOD CHEMISTRY; COST; ENVIRONMENTAL SUSTAINABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HEMATOLOGY; HUMAN; INFECTION; LABORATORY; PATHOGENESIS; PUBLIC HEALTH; REAL TIME POLYMERASE CHAIN REACTION; RESEARCH; TRAINING;

BIOMEDICAL RESEARCH; BIOTERRORISM; CIVIL DEFENSE; COMMUNICABLE DISEASES; CONTAINMENT OF BIOHAZARDS; EUROPE; HUMANS; SAFETY MANAGEMENT; SECURITY MEASURES;

EID: 84875077290     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003105     Document Type: Article

References (20)

1. European Commission (2007) "Decisions adopted jointly by the European Parliament and the Council" under Health Programme 2008-2013. Retrieved November 3, 2012 from http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2007:301:003:0013:EN:PDF.
2. Nisii C, Castilletti C, Di Caro A, Capobianchi MR, Brown D, et al. (2009) The European network of Biosafety-Level-4 laboratories: enhancing European preparedness for new healththreats. Clin Microbiol Infect 15 (8):: 720-726.
3. Ippolito G, Fusco FM, Di Caro A, Nisii C, Pompa MG, et al. (2009) Facing the threat of highly infectious diseases in Europe: the need for a networking approach. Clin Microbiol Infect 15 (8):: 706-710.
4. Ippolito G, Nisii C, Capobianchi MR, (2008) Networking for infectious-disease emergencies in Europe. Nat Rev Microbiol 6 (7):: 564.
5. Baka A, Fusco FM, Puro V, Vetter N, Skinhoj P, et al. (2007) A core curriculum for health care workers on training in management of highly infectious diseases. Euro Surveill 12 (6):: 5-6 Retrieved November 18, 2012, from http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=716.
6. Bannister B, Prygodzicz A, Ippolito G, (2009) ETIDE Working Group (2009) Training health care workers to face highly infectious diseases. Clin Microbiol Infect 15 (8):: 740-742.
7. European Commission (2012) Harmonizing European Initiatives of high-level Biocontainment Laboratories (HEIBL), Conference No. 20084152 under EU Health Programme 2008-2013. Retrieved November 3, 2012, from http://ec.europa.eu/eahc/projects/database.html?prjno=20084152.
8. European Commission (2010) European Research Infrastructure on Highly Pathogenic Agents (ERINHA). Supported under the capacities work programme of the 7th framework programme 2007-2013. Retrieved November 3, 2012, from http://www.erinha.eu.
9. European Commission (2011) Quality Assurance Exercises and Networking on the Detection of Highly Infectious Pathogens (QUANDHIP). Joint Action No. 20102102 of the Executive Agency for Health and Consumers (EAHC). Retrieved November 3, 2012, from http://www.quandhip.eu.
10. United States Government Accountability Office (2007) High-containment biosafety laboratories: preliminary observations on the oversight of the proliferation of BSL-3 and BSL-4 laboratories in the United States. Retrieved November 3, 2012, from http://www.absa.org/leg/0712GAOHighContainmentLabsReport.pdf.
11. LeDuc JW, Anderson K, Bloom ME, Carrion R Jr, Feldmann H, et al. (2009) Potential impact of a 2-person security rule on Biosafety Level 4 laboratory workers. Emerg Infect Dis 15 (7):: 1 Retrieved November 18, 2012, from http://wwwnc.cdc.gov/eid/article/15/7/08-1523_article.htm.
12. Ippolito G, Nisii C, Caro AD, Brown D, Gopal R, et al. (2009) European perspective of 2-person rule for biosafety level 4 laboratories. Emerg Infect Dis 15 (11):: 1858.
13. Onyango CO, Opoka ML, Ksiazek TG, Formenty P, Abdullahi A, et al. (2007) Laboratory diagnosis of ebola haermorrhagic fever during an outbreak in Yambio, Sudan, 2004. J Infect Dis 196: 193-198.
14. Towner JS, Sealy TK, Ksiazek TG, Nichol ST, (2007) High-throughput molecular detection of haemorrhagic fever virus threats with applications for outbreak settings. J Infec Dis 196: 205-212.
15. Towner JS, Khristova ML, Sealy TK, Vincent MJ, Erickson BR, et al. (2006) Marburgvirus genomics and association with a large haemorrhagic fever outbreak in Angola. J Virol 80: 6497-6516.
16. Grolla A, Lucht A, Dick D, Strong JE, Feldmann H, (2005) Laboratory diagnosis of Ebola and Marburg haemorrhagic fever. Bull Soc Pathol Exot 98: 205-209.
17. Towner JS, Rollin PE, Bausch DG, Sanchez A, Crary SM, et al. (2004) Rapid diagnosis of Ebola haemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 78: 4330-4341.
18. Grolla A, Jones SM, Fernando L, Strong JE, Ströher U, et al. (2011) The use of a mobile laboratory unit in support of patient management and epidemiological surveillance during the 2005 Marburg Outbreak in Angola. PLoS Negl Trop Dis 5: e1183 doi:10.1371/journal.pntd.0001183.
19. Wildlife Conservation Society (2007) "One World - One Health" event 2007-2009. Retrieved November 3, 2012, from http://oneworldonehealth.org/.
20. World Health Organization (2005) International health regulations. Retrieved November 3, 2012, from http://www.who.int/ihr/en/.